BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

127 related articles for article (PubMed ID: 38442713)

  • 1. Can we detect biomarkers of oral squamous cell carcinoma from saliva or mouth swabs?
    Gaw G; Gribben M
    Evid Based Dent; 2022 Mar; 23(1):32-33. PubMed ID: 35338327
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Current advances in noninvasive methods for the diagnosis of oral squamous cell carcinoma: a review.
    Wang S; Yang M; Li R; Bai J
    Eur J Med Res; 2023 Jan; 28(1):53. PubMed ID: 36707844
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Beta-defensin index: A functional biomarker for oral cancer detection.
    Ghosh SK; Man Y; Fraiwan A; Waters C; McKenzie C; Lu C; Pfau D; Kawsar H; Bhaskaran N; Pandiyan P; Jin G; Briggs F; Zender CC; Rezaee R; Panagakos F; Thuener JE; Wasman J; Tang A; Qari H; Wise-Draper T; McCormick TS; Madabhushi A; Gurkan UA; Weinberg A
    Cell Rep Med; 2024 Mar; 5(3):101447. PubMed ID: 38442713
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Human beta-defensin-1 suppresses tumor migration and invasion and is an independent predictor for survival of oral squamous cell carcinoma patients.
    Han Q; Wang R; Sun C; Jin X; Liu D; Zhao X; Wang L; Ji N; Li J; Zhou Y; Ye L; Liang X; Jiang L; Liao G; Dan H; Zeng X; Chen Q
    PLoS One; 2014; 9(3):e91867. PubMed ID: 24658581
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Human beta-defensin-1, -2, and -3 exhibit opposite effects on oral squamous cell carcinoma cell proliferation.
    Winter J; Pantelis A; Reich R; Martini M; Kraus D; Jepsen S; Allam JP; Novak N; Wenghoefer M
    Cancer Invest; 2011 Mar; 29(3):196-201. PubMed ID: 21280982
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Loss of human beta-defensin 1, 2, and 3 expression in oral squamous cell carcinoma.
    Joly S; Compton LM; Pujol C; Kurago ZB; Guthmiller JM
    Oral Microbiol Immunol; 2009 Oct; 24(5):353-60. PubMed ID: 19702947
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Human beta-defensin-3 (hBD-3) upregulated by LPS via epidermal growth factor receptor (EGFR) signaling pathways to enhance lymphatic invasion of oral squamous cell carcinoma.
    Shuyi Y; Feng W; Jing T; Hongzhang H; Haiyan W; Pingping M; Liwu Z; Zwahlen RA; Hongyu Y
    Oral Surg Oral Med Oral Pathol Oral Radiol Endod; 2011 Nov; 112(5):616-25. PubMed ID: 22035653
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Decreased gene expression of human beta-defensin-1 in the development of squamous cell carcinoma of the oral cavity.
    Wenghoefer M; Pantelis A; Dommisch H; Reich R; Martini M; Allam JP; Novak N; Bergé S; Jepsen S; Winter J
    Int J Oral Maxillofac Surg; 2008 Jul; 37(7):660-3. PubMed ID: 18346877
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Detecting salivary host and microbiome RNA signature for aiding diagnosis of oral and throat cancer.
    Banavar G; Ogundijo O; Julian C; Toma R; Camacho F; Torres PJ; Hu L; Chandra T; Piscitello A; Kenny L; Vasani S; Batstone M; Dimitrova N; Vuyisich M; Amar S; Punyadeera C
    Oral Oncol; 2023 Oct; 145():106480. PubMed ID: 37454545
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Epidemiology, Risk Factors, and Prevention of Head and Neck Squamous Cell Carcinoma.
    Barsouk A; Aluru JS; Rawla P; Saginala K; Barsouk A
    Med Sci (Basel); 2023 Jun; 11(2):. PubMed ID: 37367741
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The Role of TAMs in Tumor Microenvironment and New Research Progress.
    Feng Y; Ye Z; Song F; He Y; Liu J
    Stem Cells Int; 2022; 2022():5775696. PubMed ID: 36004381
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Integration of tumor extrinsic and intrinsic features associates with immunotherapy response in non-small cell lung cancer.
    Lau D; Khare S; Stein MM; Jain P; Gao Y; BenTaieb A; Rand TA; Salahudeen AA; Khan AA
    Nat Commun; 2022 Jul; 13(1):4053. PubMed ID: 35831288
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Validation of genomic and transcriptomic models of homologous recombination deficiency in a real-world pan-cancer cohort.
    Leibowitz BD; Dougherty BV; Bell JSK; Kapilivsky J; Michuda J; Sedgewick AJ; Munson WA; Chandra TA; Dry JR; Beaubier N; Igartua C; Taxter T
    BMC Cancer; 2022 May; 22(1):587. PubMed ID: 35643464
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Salivary
    Zhang X; Zhang Y; Gui X; Zhang Y; Zhang Z; Chen W; Zhang X; Wang Y; Zhang M; Shang Z; Xin Y; Zhang Y
    iScience; 2022 May; 25(5):104203. PubMed ID: 35479401
    [No Abstract]   [Full Text] [Related]  

  • 15. Characteristics and outcome differences in male and female oral cavity cancer patients in Taiwan.
    Lee YC; Young CK; Chien HT; Chin SC; Iandelli A; Liao CT; Tsao CK; Kang CJ; Huang SF
    Medicine (Baltimore); 2021 Nov; 100(44):e27674. PubMed ID: 34871246
    [TBL] [Abstract][Full Text] [Related]  

  • 16.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 17.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 18.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 19.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 20.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 7.